Sana Biotechnology, Inc. (NASDAQ:SANA)’s stock price fell 14.1% on Tuesday . The company traded as low as $31.57 and last traded at $32.51. 525,257 shares changed hands during trading, a decline of 48% from the average session volume of 1,018,246 shares. The stock had previously closed at $37.85.
Sana Biotechnology Company Profile (NASDAQ:SANA)
Sana Biotechnology, Inc develops and delivers engineered cells as medicine for patients. It identifies and develops potential product candidates; and executes preclinical studies. The company develops technologies to repair and control genes in cells; and replace any cell in the body. Sana Biotechnology, Inc was formerly known as FD Therapeutics, Inc and changed its name to Sana Biotechnology, Inc in September 2018.
See Also: Stop Order
Receive News & Ratings for Sana Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sana Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.